Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas

Clinical trial NCT06792734 · RECRUITING

Trial details

NCT number: NCT06792734
Sponsor: Bantam Pharmaceuticals
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, B-Cell

Start date: 2025-02-14
Primary completion: 2027-02-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.